Development and validation of a new RP-HPLC method for the determination of aprepitant in solid dosage forms

Tropical Journal of Pharmaceutical Research

Volumn 10, Issue 4, 2011, Pages 491-497

  Nama, Sreekanth ^a   Chandu, Babu R ^b   Awen, Bahlul Z ^b   Khagga, Mukkanti ^c  

^a JIMMA UNIVERSITY   (Ethiopia)

^b Al Jabal Al Gharbi University   (Libyan Arab Jamahiriya)

^c JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY   (India)

Author keywords

Analysis; Aprepitant; Isocratic; Pharmaceutical dosage forms; RP HPLC; Validation

Indexed keywords

APREPITANT;

ACCURACY; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG CAPSULE; DRUG DETERMINATION; DRUG STRUCTURE; ENVIRONMENTAL TEMPERATURE; FLOW RATE; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MOLECULAR WEIGHT; PARTICLE SIZE; PROCESS OPTIMIZATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

EID: 80052594668     PISSN: 15965996     EISSN: 15969827     Source Type: Journal    
DOI: 10.4314/tjpr.v10i4.15     Document Type: Article

References (8)

1. Sorbera LA, Castaner J, Bayes M, Silvestre J. Drugs of the Future. Drugs Fut. 2002; 27(3): 211.
2. Mats B, Richard J, Donald Burnsb H, Michael R, David S, Scott A, Kevin J, Mattias O, Gunnar A, Bengt L, et al. Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant. Bio Psych. 2004; 55(10): 1007-1012.
3. Constanzer ML, Chavez-Eng CM, Dru J, Kline WF and Matuszewski BK. Determination of a novel substance P inhibitor in human plasma by high-performance liquid chromatography with atmospheric pressure chemical ionization mass spectrometric detection using single and triple quadrupole detectors. J Chromatogr B Analyt Technol Bio Med Life Sci. 2004; 807(2): 243-250.
4. Chavez Eng CM, Constanzer ML and Matuszewski BK. Simultaneous determination of Aprepitant and two metabolites in human plasma by highperformance liquid chromatography with tandem mass spectrometric detection. J Pharm Biomed Anal. 2004; 35: 1213-1229.
5. Peter J, Ahmed A, Yan W. An HPLC chromatographic reactor approach for investigating the hydrolytic stability of a pharmaceutical compound. J Pharm Biomed Anal. 2006; 41(3): 883-890.
6. Di Wu, Dustin J, Xianguo Z, Steven D, Jeffrey S. A sensitive and rapid liquid chromatographytandem mass spectrometry method for the quantification of the novel neurokinin-1R antagonist aprepitant in rhesus macaque plasma, and cerebral spinal fluid, and human plasma with application in translational NeuroAIDs research. J Pharm Biomed Anal. 2009; 49(3): 739-745.
7. Roy H, George XZ, Yadan W, Louis C, Tao W, Robert M, Anant V. Characterization and Quantitation of Aprepitant Drug Substance Polymorphs by Attenuated Total Reflectance Fourier Transform Infrared Spectroscopy. Anal Chem. 2003; 75(3): 605-611.
8. Kiran KV, Appala RN, Shabana B, Seshagiri RJVLN, Satyanarayana T. The Estimation of Aprepitant in Capsules Dosage forms by RP-HPLC. Res J Pharm & Tech. 2009; 2(2): 412-414.